Las Vegas, NV -- (SBWIRE) -- 10/24/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, Sify Technologies Limited (ADR) (NASDAQ:SIFY), Pacific Biosciences of California (NASDAQ:PACB), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), EDENOR S.A. (ADR) (NYSE:EDN)
Sify Technologies Limited (ADR) (NASDAQ:SIFY) was a volume gainer of 1.58 million shares and the average volume of the stock remained 237,202 shares. The stock opened the session at $2.30 and finished at the end of the day at $2.18 and the stock plunged -20.12%.The market capitalization of the stock remained 389.16 million. The half-yearly trend of the stock remained positive 23.39 %. Sify Technologies Limited (Sify) is an integrated Internet, network and electronic commerce services companies in India. The Company’s services enable its business and consumers to communicate, transmit and share information, access online content and conduct business remotely using its private data network or the Internet. It operates in four segments: Corporate network/data services, which provides Internet, connectivity, security and consulting, hosting and managed service solutions; Internet access services, from homes and through cybercafes; Online portal services and content offerings, and Other services, such as development of e-learning software.
Will SIFY Bounce Back After yesterday’s Sharp Sell off? Find Out Here
In the preceding trading session, Pacific Biosciences of California (NASDAQ:PACB) exchanged 2.29 million shares and the average volume remained 1.29 million shares. The stock closed the session at $4.26 with the drop of -18.86%. Tracking three months and 6 months trends, the stock was at of 48.95% and 78.24%, respectively. Pacific Biosciences, Inc. develops Deoxyribonucleic Acid (DNA) sequencing platform. The Company designs and develops a method for single-molecule DNA sequencing that was developed through collaboration between the research groups of Harold Craighead and Watt Webb at Cornell University, United States.
Is it the Right to Grab PACB after the Recent Slump? Get Free Trend Analysis Here
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) decreased -18.36% and its closing price was $4.03. The volume of the stock was 3.81 million shares and the average volume remained 1.12 million shares. Yesterday, the stock traded amid the day price range of $3.97 - $4.78. The market capitalization of the stock remained 336.18 million. The beta of the stock remained 1.72. ZIOPHARM Oncology, Inc., is a biotechnology company. The Company employs gene expression and control technology to deliver deoxyribonucleic acid (DNA) for the treatment of cancer. The Company's technology employs Intrexon Corporation's RheoSwitch Therapeutic System to turn on and off, and precisely modulate, gene expression at the cancer site in order to improve the therapeutic index.
Will ZIOP Reach the Bottom after Yesterday’s Correction? Find Out Here
EDENOR S.A. (ADR) (NYSE:EDN) exchanged 137,183 shares in the previous trading session, and its average trading remained 109,634 shares. EDN dropped -17.74% and it closed the trading at $5.38. The market capitalization of the stock remained 217.17 million. YTD trend of the stock was positive 187.7%. Empresa Distribuidora y Comercializadora Norte SA (EDENOR) is an Argentina-based company engaged, together with its fully consolidated subsidiaries Aeseba SA (AESEBA) and Empresa Distribuidora Electrica Regional SA (EMDERSA), in the distribution of electric power.
Has EDN Found The Bottom and Ready To Move Up? Find Out Here
About:Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)